학술논문

Evaluation of Lupus Cases Related to TNF Inhibitors in Children
Document Type
article
Source
The Journal of Pediatric Academy, Vol 4, Iss 4, Pp 146-148 (2023)
Subject
child
infliximab
systemic lupus erythematosus
Pediatrics
RJ1-570
Language
English
ISSN
2718-0875
Abstract
Systemic lupus erythematosus (SLE) due to anti-tumor necrosis factor (TNF) agents is a rare entity. We reported three cases who developed lupus-like syndrome while receiving infliximab therapy for various reasons. All cases demonstrated clinical and laboratory findings of SLE. And all of them needed treatment. We would like to emphasize that the risk of anti-TNF-alpha-induced lupus should be kept in mind in patients receiving anti-TNF therapy for any reason.